⌘K

Home/Filings/4/0001493152-24-012069

4//SEC Filing

Arrow Alexander K. 4

Accession 0001493152-24-012069

CIK 0001022899other

View on SEC.gov Company Profile

Filed

Mar 28, 8:00 PM ET

Accepted

Mar 29, 9:29 PM ET

Size

5.6 KB

Accession

0001493152-24-012069

Insider Transaction Report

Form 4

Period: 2024-03-25

Protagenic Therapeutics, Inc.\newPTIX

Arrow Alexander K.

Chief Financial Officer

Transactions

Award
PTIX Common stock Options
2024-03-25$1.74/sh+100,000$174,000→ 100,000 total
Exercise: $1.74From: 2027-03-25Exp: 2034-03-25→ PTIX Common Stock, Par Value $0.0001 (100,000 underlying)

Documents

1 file

4
ownership.xmlPrimary

Issuer

Protagenic Therapeutics, Inc.\new

CIK 0001022899

Entity typeother

Related Parties

1

filerCIK 0001497166

Filing Metadata

Form type: 4
Filed: Mar 28, 8:00 PM ET
Accepted: Mar 29, 9:29 PM ET
Size: 5.6 KB

View on SEC.gov